Cargando…

The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?

SIMPLE SUMMARY: As immune checkpoint inhibitor (ICI) therapy against PD1 is only efficient in a small proportion of OSCC patients, identification of further checkpoints might improve therapy response by enabling combination ICI treatment. The aim of this study was to analyze the gene- and protein-ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trumet, Leah, Weber, Manuel, Hahn, Alina, Kunater, Lina, Geppert, Carol, Glajzer, Jacek, Struckmeier, Ann-Kristin, Möst, Tobias, Lutz, Rainer, Kesting, Marco, Ries, Jutta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093349/ https://www.ncbi.nlm.nih.gov/pubmed/37046787 http://dx.doi.org/10.3390/cancers15072126

Ejemplares similares

Alterations in macrophage polarization in the craniofacial and extracranial skeleton after zoledronate application and surgical interventions – an in vivo experiment
por: Struckmeier, Ann-Kristin, et al.
Publicado: (2023)

Postoperative Changes in Systemic Immune Tolerance Following Major Oncologic versus Minor Maxillofacial Surgery
por: Trumet, Leah, et al.
Publicado: (2023)

Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer
por: Weber, Manuel, et al.
Publicado: (2022)

Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response
por: Olmos, Manuel, et al.
Publicado: (2021)

Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck – a case series and review of literature
por: Olmos, Manuel, et al.
Publicado: (2022)

Macrophage and T-Cell Infiltration and Topographic Immune Cell Distribution in Non-Melanoma Skin Cancer of the Head and Neck
por: Frohwitter, Gesche, et al.
Publicado: (2022)

The Special Developmental Biology of Craniofacial Tissues Enables the Understanding of Oral and Maxillofacial Physiology and Diseases
por: Weber, Manuel, et al.
Publicado: (2021)

Craniofacial Osteosarcoma—Pilot Study on the Expression of Osteobiologic Characteristics and Hypothesis on Metastasis
por: Weber, Manuel, et al.
Publicado: (2020)

Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo
por: Weber, Manuel, et al.
Publicado: (2021)

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
por: Wehrhan, Falk, et al.
Publicado: (2019)

CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

Diagnostic accuracy of contrast-enhanced computed tomography in assessing cervical lymph node status in patients with oral squamous cell carcinoma
por: Struckmeier, Ann-Kristin, et al.
Publicado: (2023)

Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas
por: Wehrhan, Falk, et al.
Publicado: (2018)

Investigation of the Expression of Inflammatory Markers in Oral Biofilm Samples in Patients with Systemic Scleroderma and the Association with Clinical Periodontal Parameters—A Preliminary Study
por: Buchbender, Mayte, et al.
Publicado: (2021)

An ex vivo model for education and training of unilateral cleft lip surgery
por: Lutz, Rainer, et al.
Publicado: (2023)

Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis
por: Ohtsuki, Shozo, et al.
Publicado: (2023)

Early MDO with a Virtually Planned Distractor in a Neonate with Pierre Robin Sequence
por: Lutz, Rainer, et al.
Publicado: (2022)

An ex vivo model for education and training of bilateral cleft lip surgery
por: Lutz, Rainer, et al.
Publicado: (2023)

Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients—a preliminary study
por: Buchbender, Mayte, et al.
Publicado: (2021)

Prevalence of carotid artery calcification detected by different dental imaging techniques and their relationship with cardiovascular risk factors, age and gender
por: Möst, Tobias, et al.
Publicado: (2023)

CD96 as a Potential Immune Regulator in Cancers
por: Feng, Shikai, et al.
Publicado: (2023)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
por: Ries, Jutta, et al.
Publicado: (2021)

Coming of Age: CD96 Emerges as Modulator of Immune Responses
por: Georgiev, Hristo, et al.
Publicado: (2018)

MicroRNA-183/96/182 cluster in immunity and autoimmunity
por: Wang, Zhuang, et al.
Publicado: (2023)

Systematic review of craniofacial osteosarcoma regarding different clinical, therapeutic and prognostic parameters
por: Weber, Verena, et al.
Publicado: (2023)

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
por: Grywalska, Ewelina, et al.
Publicado: (2018)

Hematologic Complications of Immune Checkpoint Inhibitors
por: Davis, Elizabeth J., et al.
Publicado: (2019)

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer
por: Semrau, Sabine, et al.
Publicado: (2021)

Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
por: Zhang, Qiang, et al.
Publicado: (2020)

Galectin 3 expression in primary oral squamous cell carcinomas
por: Weber, Manuel, et al.
Publicado: (2017)

Immune checkpoint inhibitors
por: Hui, Enfu
Publicado: (2019)

Immune checkpoint inhibitors
por: Kroemer, Guido, et al.
Publicado: (2021)

Immune checkpoint receptors: homeostatic regulators of immunity
por: Riva, Antonio, et al.
Publicado: (2018)

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
por: Zhang, Qiang, et al.
Publicado: (2020)

Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
por: Grywalska, Ewelina, et al.
Publicado: (2019)

High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
por: Kuo, Alyce M., et al.
Publicado: (2022)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)

Immune Checkpoints in Viral Infections
por: Cai, Huiming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bsu6kq3hp4chmis17lfdl8aov3